Skip to main content
Erschienen in: Cancer Causes & Control 10/2012

01.10.2012 | Original paper

Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant

verfasst von: Crystal Speaks, Katherine A. McGlynn, Michael B. Cook

Erschienen in: Cancer Causes & Control | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The current working model of type II testicular germ cell tumor (TGCT) pathogenesis states that carcinoma in situ arises during embryogenesis, is a necessary precursor, and always progresses to cancer. An implicit condition of this model is that only in utero exposures affect the development of TGCT in later life. In an age-period-cohort analysis, this working model contends an absence of calendar period deviations. We tested this contention using data from the SEER registries of the United States.

Methods

We assessed age-period-cohort models of TGCTs, seminomas, and nonseminomas for the period 1973–2008. Analyses were restricted to whites diagnosed at ages 15–74 years. We tested whether calendar period deviations were significant in TGCT incidence trends adjusted for age deviations and cohort effects.

Results

This analysis included 32,250 TGCTs (18,475 seminomas and 13,775 nonseminomas). Seminoma incidence trends have increased with an average annual percentage change in log-linear rates (net drift) of 1.25 %, relative to just 0.14 % for nonseminoma. In more recent time periods, TGCT incidence trends have plateaued and then undergone a slight decrease. Calendar period deviations were highly statistically significant in models of TGCT (p = 1.24−9) and seminoma (p = 3.99−14), after adjustment for age deviations and cohort effects; results for nonseminoma (p = 0.02) indicated that the effects of calendar period were much more muted.

Conclusion

Calendar period deviations play a significant role in incidence trends of TGCT, which indicates that postnatal exposures are etiologically relevant.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Skakkebaek NE, Berthelsen JG, Muller J (1982) Carcinoma-in situ of the undescended testis. Urol Clin North Am 9(3):377–385PubMed Skakkebaek NE, Berthelsen JG, Muller J (1982) Carcinoma-in situ of the undescended testis. Urol Clin North Am 9(3):377–385PubMed
3.
Zurück zum Zitat Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, Harrison NJ, Schwager C, Abdollahi A, Huber PE, Brunak S, Gjerdrum LM, Moore HD, Andrews PW, Skakkebaek NE, Rajpert-De Meyts E, Leffers H (2009) Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69(12):5241–5250. doi:10.1158/0008-5472.CAN-08-4554 PubMedCrossRef Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, Harrison NJ, Schwager C, Abdollahi A, Huber PE, Brunak S, Gjerdrum LM, Moore HD, Andrews PW, Skakkebaek NE, Rajpert-De Meyts E, Leffers H (2009) Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69(12):5241–5250. doi:10.​1158/​0008-5472.​CAN-08-4554 PubMedCrossRef
4.
Zurück zum Zitat Oosterhuis JW, Kersemaekers AM, Jacobsen GK, Timmer A, Steyerberg EW, Molier M, Van Weeren PC, Stoop H, Looijenga LH (2003) Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report. APMIS 111(1):32–40 (discussion 41-32)PubMedCrossRef Oosterhuis JW, Kersemaekers AM, Jacobsen GK, Timmer A, Steyerberg EW, Molier M, Van Weeren PC, Stoop H, Looijenga LH (2003) Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report. APMIS 111(1):32–40 (discussion 41-32)PubMedCrossRef
5.
Zurück zum Zitat von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, Jacobsen GK, Berthelsen JG, Skakkebaek NE (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 293(6559):1398–1401CrossRef von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, Jacobsen GK, Berthelsen JG, Skakkebaek NE (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 293(6559):1398–1401CrossRef
6.
Zurück zum Zitat Skakkebaek NE (1978) Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2(3):157–170PubMedCrossRef Skakkebaek NE (1978) Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2(3):157–170PubMedCrossRef
7.
Zurück zum Zitat Giwercman A, Skakkebaek NE (1993) Carcinoma in situ of the testis: biology, screening and management. Eur Urol 23(Suppl 2):19–21PubMed Giwercman A, Skakkebaek NE (1993) Carcinoma in situ of the testis: biology, screening and management. Eur Urol 23(Suppl 2):19–21PubMed
8.
Zurück zum Zitat Aalen OO, Tretli S (1999) Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 10(4):285–292PubMedCrossRef Aalen OO, Tretli S (1999) Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 10(4):285–292PubMedCrossRef
9.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef
10.
Zurück zum Zitat Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef
11.
Zurück zum Zitat McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef
13.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, Moller H (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, Moller H (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef
14.
Zurück zum Zitat Liu S, Wen SW, Mao Y, Mery L, Rouleau J (1999) Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health 90(3):176–180PubMed Liu S, Wen SW, Mao Y, Mery L, Rouleau J (1999) Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health 90(3):176–180PubMed
15.
Zurück zum Zitat Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyczynski JE, Akre O (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyczynski JE, Akre O (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed
16.
Zurück zum Zitat Liu S, Semenciw R, Waters C, Wen SW, Mery LS, Mao Y (2000) Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 29(5):826–831PubMedCrossRef Liu S, Semenciw R, Waters C, Wen SW, Mery LS, Mao Y (2000) Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 29(5):826–831PubMedCrossRef
18.
Zurück zum Zitat Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16(5):1007–1011PubMedCrossRef Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16(5):1007–1011PubMedCrossRef
20.
Zurück zum Zitat Rosenberg PS, Anderson WF (2010) Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 29(11):1228–1238. doi:10.1002/sim.3865 PubMed Rosenberg PS, Anderson WF (2010) Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 29(11):1228–1238. doi:10.​1002/​sim.​3865 PubMed
23.
Zurück zum Zitat Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF (2009) Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev 18(8):2256–2261. doi:10.1158/1055-9965.EPI-09-0240 PubMedCrossRef Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF (2009) Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev 18(8):2256–2261. doi:10.​1158/​1055-9965.​EPI-09-0240 PubMedCrossRef
24.
Zurück zum Zitat Fritz AG (2000) International classification of diseases for oncology: ICD-O, 3rd edn. World Health Organization, Geneva Fritz AG (2000) International classification of diseases for oncology: ICD-O, 3rd edn. World Health Organization, Geneva
25.
Zurück zum Zitat World Health Organization (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, Oxford University Press [distributor], Oxford World Health Organization (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, Oxford University Press [distributor], Oxford
27.
Zurück zum Zitat Holford TR (1983) The estimation of age, period and cohort effects for vital rates. Biometrics 39(2):311–324PubMedCrossRef Holford TR (1983) The estimation of age, period and cohort effects for vital rates. Biometrics 39(2):311–324PubMedCrossRef
28.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates II: Age-period-cohort models. Stat Med 6(4):469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates II: Age-period-cohort models. Stat Med 6(4):469–481PubMedCrossRef
29.
Zurück zum Zitat Robertson C, Gandini S, Boyle P (1999) Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol 52(6):569–583PubMedCrossRef Robertson C, Gandini S, Boyle P (1999) Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol 52(6):569–583PubMedCrossRef
32.
Zurück zum Zitat Lerro CC, McGlynn KA, Cook MB (2010) A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer 103(9):1467–1474PubMedCrossRef Lerro CC, McGlynn KA, Cook MB (2010) A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer 103(9):1467–1474PubMedCrossRef
33.
Zurück zum Zitat McGlynn KA, Cook MB (2009) The epidemiology of testicular cancer. In: Cooney KA, Foulkes WD (eds) Male reproductive cancers: epidemiology, pathology and genetics, vol Cancer Genetics series. Springer Publications, New York McGlynn KA, Cook MB (2009) The epidemiology of testicular cancer. In: Cooney KA, Foulkes WD (eds) Male reproductive cancers: epidemiology, pathology and genetics, vol Cancer Genetics series. Springer Publications, New York
34.
Zurück zum Zitat Daling JR, Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM (2009) Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115(6):1215–1223. doi:10.1002/cncr.24159 PubMedCrossRef Daling JR, Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM (2009) Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115(6):1215–1223. doi:10.​1002/​cncr.​24159 PubMedCrossRef
36.
Zurück zum Zitat Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835–1841PubMedCrossRef Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835–1841PubMedCrossRef
37.
Zurück zum Zitat Wanderas EH, Tretli S, Fossa SD (1995) Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 31A(12):2044–2048PubMedCrossRef Wanderas EH, Tretli S, Fossa SD (1995) Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 31A(12):2044–2048PubMedCrossRef
39.
Zurück zum Zitat Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76(11):2343–2350PubMedCrossRef Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76(11):2343–2350PubMedCrossRef
Metadaten
Titel
Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant
verfasst von
Crystal Speaks
Katherine A. McGlynn
Michael B. Cook
Publikationsdatum
01.10.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0036-5

Weitere Artikel der Ausgabe 10/2012

Cancer Causes & Control 10/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.